FDA Panel Says LASIK Merits Stronger Warnings

Law360, New York (April 29, 2008, 12:00 AM EDT) -- The U.S. Food and Drug Administration is reportedly planning to issue a stronger warning about the risks associated with the popular vision-correcting LASIK eye surgery following a panel meeting on Friday.

The FDA's Ophthalmic Devices Panel met on Friday to discuss LASIK's impact on patients' quality of life, the Associated Press and others reported.

Although a task force convened last year by the FDA and other agencies determined that 95.4% of LASIK patients are satisfied with their surgery, some patients report permanently distorted vision or eye...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.